Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + BHV-0223
|
DCDK0ZH
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Acetohydroxamic Acid + BHV-0223
|
DCL2XUG
|
Acetohydroxamic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Allopurinol + BHV-0223
|
DCGJVWB
|
Allopurinol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Arfolitixorin + BHV-0223
|
DCGB4W8
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Gefitinib
|
DCRWL9K
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Paromomycin
|
DC55TZU
|
Paromomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Epinephrine
|
DC9O15D
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + PMID28460551-Compound-2
|
DCKNRM0
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Sivelestat
|
DCIL2ES
|
Sivelestat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Fomepizole
|
DCW6M4I
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + IT-141
|
DCVR60C
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Testosterone cypionate
|
DC6UY5S
|
Testosterone cypionate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Terameprocol
|
DC5Z9WU
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Emetine
|
DCGI2CD
|
Emetine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Chlorzoxazone
|
DC1XC3S
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Docetaxel
|
DCJ4GHV
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + JZL195
|
DC6K6MV
|
JZL195
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Ginsenoside Rb1
|
DCZZXJT
|
Ginsenoside Rb1
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Armodafinil
|
DCM7F78
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Zaleplon
|
DC66AAO
|
Zaleplon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Naringenin
|
DCBXAD3
|
Naringenin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Clopidogrel
|
DCFEYM2
|
Clopidogrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + BIO-300
|
DC5L0GF
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Diazoxide
|
DCJNV3G
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Idarubicin
|
DCVCPD6
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[2] |
BHV-0223 + Probenecid
|
DC5NQED
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Bortezomib
|
DCJ45CG
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Methylene blue
|
DC8WRQE
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Oxyphenbutazone
|
DC6UPS0
|
Oxyphenbutazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Eptifibatide
|
DCJREEI
|
Eptifibatide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Brincidofovir
|
DC7RANM
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Amantadine
|
DCSZXIT
|
Amantadine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Hyodeoxycholic acid
|
DC7DI0F
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Hydralazine
|
DC1I72Y
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Pyronaridine
|
DCTZF98
|
Pyronaridine
|
DD2 (Cell Line: DD2)
|
[2] |
BHV-0223 + Cisatracurium
|
DC4P7OP
|
Cisatracurium
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Lacosamide
|
DCI5MN0
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Doxorubicin
|
DC6UIXQ
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Auranofin
|
DC75DFZ
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Cerivastatin
|
DC9P25C
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Enoxacin
|
DCMUTEJ
|
Enoxacin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
BHV-0223 + Lumefantrine
|
DCK6LV6
|
Lumefantrine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
BHV-0223 + Mefloquine
|
DCHMUYW
|
Mefloquine
|
Hepatoblastoma (Cell Line: HB3)
|
[3] |
Cerivastatin + BHV-0223
|
DCETT3E
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chlorambucil + BHV-0223
|
DCBD8CA
|
Chlorambucil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chloroquine + BHV-0223
|
DC4HJER
|
Chloroquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cilostazol + BHV-0223
|
DC5OBGO
|
Cilostazol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Etonogestrel + BHV-0223
|
DCPK5EO
|
Etonogestrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Everolimus + BHV-0223
|
DCDOCX1
|
Everolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Hydralazine + BHV-0223
|
DCMQDGQ
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
L-165041 + BHV-0223
|
DCAP8SE
|
L-165041
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Levamisole + BHV-0223
|
DC0G0FF
|
Levamisole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Loperamide + BHV-0223
|
DC8VCKT
|
Loperamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Maprotiline + BHV-0223
|
DC634JK
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Maraviroc + BHV-0223
|
DC5JJSC
|
Maraviroc
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Metformin + BHV-0223
|
DCQQU9I
|
Metformin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Methoxsalen + BHV-0223
|
DCNGDNI
|
Methoxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Olmesartan medoxomil + BHV-0223
|
DCME9AC
|
Olmesartan medoxomil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Pepstatin + BHV-0223
|
DCLXPI6
|
Pepstatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
PF-02545920 + BHV-0223
|
DC7M6QM
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
PHA-739358 + BHV-0223
|
DCWO2J8
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Quinine + BHV-0223
|
DCIHUHB
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
SCH 727965 + BHV-0223
|
DCLX0Z9
|
SCH 727965
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Theophylline + BHV-0223
|
DC9WL6Z
|
Theophylline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Topotecan + BHV-0223
|
DCJ2L5I
|
Topotecan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Trihexyphenidyl + BHV-0223
|
DCOTMHC
|
Trihexyphenidyl
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Trimethobenzamide + BHV-0223
|
DC9SYIS
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Vinblastine + BHV-0223
|
DCLD6YY
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|